Sunitinib for the First-Line Treatment of Advanced and/or Metastatic Renal Cell Carcinoma
Technology Appraisal Guidance No. 169 Source: National Institute for Health and Clinical...
Manufacturers
Click on a letter to go to manufacturers beginning with that letter.
A
- A. Menarini Pharma UK SRL
- A1 Pharmaceuticals Plc
- Abbey Pharmaceuticals Ltd
- Abbott Diabetes Care
- Abbott Laboratories Ltd
- Abbott Nutrition
- Abraxis BioScience Limited
- ABT Healthcare UK Ltd
- Actavis UK Ltd
- Actelion Pharmaceuticals UK Ltd
- Activa Healthcare Ltd
- ADI Medical Ltd
- Advancis
- Agepha GmbH
- Aguettant Ltd
- Alcon Laboratories UK Ltd
- Alembic Products Ltd
- Alexion Pharma UK Ltd
- ALK-Abello
- Allergan Ltd
- Allergy Therapeutics Ltd
- Alliance Pharmaceuticals Ltd
- Almirall Ltd
- Alphashow Ltd
- Altacor Ltd
- Altimed Ltd
- Amdipharm Plc
- Amgen Ltd
- Anglian Pharma Sales & Marketing Ltd
- Archimedes Pharma UK Limited
- Arctic Medical Ltd
- Ardern Healthcare Ltd
- Ark Therapeutics
- AS Pharma Ltd
- Astellas Pharma Ltd
- AstraZeneca UK Ltd
- Avicenna plc
- Ayrton Saunders Ltd
Top 10 Searches
Latest Guidelines
Rivaroxaban for the Prevention of Venous Thromboembolism after Total Hip or Knee Replacement in Adults
1. Guidance 1.1 Rivaroxaban, within its marketing authorisation, is recommended as an...
Amantadine, Oseltamivir and Zanamivir for the Treatment of Influenza (Review)
Technology Appraisal Guidance No. 168 Source: National Institute for Health and Clinical...
Erlotinib for the Treatment of Non-Small-Cell Lung Cancer
Technology Appraisal Guidance No. 162 Source: National Institute for Health and Clinical...
Infliximab for Acute Exacerbations of Ulcerative Colitis
Technology Appraisal Guidance No. 163 Source: National Institute for Health and Clinical...
MIMs Drug Search
Possible searches include drugs (by brand, generic ingredient or drug class), diseases and more.
Deleted products
Cumulative list of products discontinued from the UK market
in 2009.
